Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation - United Kingdom
doi 10.1038/s41409-017-0060-x

Related search